Salud Bienestar

Pfizer fourth-quarter results top estimates



    (Reuters) - Pfizer Inc on Tuesday reported better-than-expected quarterly results, helped by a rebound in sales in emerging markets.

    The largest U.S. drugmaker said it earned $6.32 billion, or 86 cents per share, in the fourth quarter. That compared with $1.44 billion, or 19 cents per share, in the year-earlier quarter.

    (Reporting by Ransdell Pierson; Editing by Jeffrey Benkoe)